REFERENCES
- Fisher B., Chin A.T., Kuo I., Kirst M., Vlahov D. Canadian Illicit Opiate Users' Views on Methadone Treatment and Other Opiate Prescription Treatment. Substance Use Misuse 2002; 37(4)495–522, this issue
- United Nations International Drug Control Programme. World Drug Report. Oxford University Press, Oxford 1997
- Rydell C.P., Everingham S.S. Controlling Cocaine. Supply Versus Demand Programs. Drug Policy Research Centre, RAND, Santa Monica, CA 1994
- Wodak A. Health, HIV Infection, Human Rights and Injecting Drug Use. Health Human Rights 1998; 2(4)24–41
- Gibson D.R., Flynn N.M., McCarthy J.J. Effectiveness of Methadone Treatment in Reducing HIV Risk Behavior and HIV Seroconversion Among Injecting Drug Users [editorial]. AIDS 1999; 13(14)1807–1818, Oct
- Metrebian N., Shanahan W., Wells B., Stimson G.V. Feasibility of Prescribing Injectable Heroin and Methadone to Opiate-Dependent Drug Users: Associated Health Gains and Harm Reductions. Med. J. Australia 1998; 168: 596–600
- D’Aunno T., Vaughn T.E. Variations in Methadone Treatment Practices: Results from a National Study. J. Am. Med. Assoc. 1992; 267: 253–258
- McLachlan C., Crofts N., Wodak A., Crowe S. The Effects of Methadone on Immune Function in Injecting Drug Users: A Review. Addiction 1993; 88(2)257–263